[Bone mineral density in school age children born preterm ]

Aída Milinarsky1, Sylvia Fischer, Vinka Giadrosich

  • 1Departamentos de Pediatría y Medicina, Facultad de Medicina, Universidad de Valparaíso, Chile. pediatria@uv.cl

Revista Medica De Chile
|January 28, 2004
PubMed

Insights

Children born preterm have lower bone mineral density at 5-7 years old. Bone mineral density in these children correlates with insulin growth factor 1 (IGF-1).

Area of Science:

  • Pediatric endocrinology
  • Bone health research
  • Neonatal follow-up studies

Context:

  • Bone mineral density (BMD) normalization timing in preterm infants is not well-established.
  • Preterm birth can impact long-term skeletal development.
  • Understanding skeletal outcomes in preterm children is crucial for growth monitoring.

Purpose:

  • To determine if bone mineral density (BMD) normalizes by 5 to 7 years of age in children born preterm.
  • To compare BMD in preterm children versus term-born controls.
  • To investigate factors associated with BMD in this cohort.

Summary:

  • A study of 26 preterm infants and 105 term controls aged 5-7 years found significantly lower bone mineral density (BMD) in the preterm group.
  • BMD in preterm children was 0.273 +/- 0.01 g/cm2 compared to 0.302 +/- 0.01 g/cm2 in term controls (p < 0.001).
  • A positive correlation was observed between bone mineral density and insulin growth factor 1 (IGF-1) levels (r = 0.49, p = 0.01).

Impact:

  • Preterm infants exhibit reduced bone mineral density (BMD) up to 7 years of age.
  • Insulin growth factor 1 (IGF-1) is a potential biomarker for bone health in preterm children.
  • Findings highlight the need for continued monitoring of bone health in individuals born preterm.
Abstract

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...